Ex Vivo Cytokine Profiling of Cryptococcus neoformans Strains Suggests Strain-Specific Immune Modulation: A Cross-Sectional Study
- PMID: 40772174
- PMCID: PMC12326209
- DOI: 10.7759/cureus.87404
Ex Vivo Cytokine Profiling of Cryptococcus neoformans Strains Suggests Strain-Specific Immune Modulation: A Cross-Sectional Study
Abstract
Cryptococcal meningitis (CM) remains a major cause of mortality among people living with human immunodeficiency virus (HIV), especially in sub-Saharan Africa. The interplay between fungal genotype and host immune response is critical in determining disease outcome. We conducted ex vivo cytokine profiling using peripheral blood from HIV-positive and HIV-negative adults stimulated with heat-inactivated whole-cell antigens from two Cryptococcus neoformans strains: the reference strain H99 and the genetically distinct UgCl377 clinical strain. These strains differ at multiple loci, including the CNAG_04922 gene. Luminex-based quantification revealed that H99 induced significantly higher levels of CD40-ligand, IL-10, IL-12p70, IL-13, IL-15, and IL-33. These cytokines reflect pro-inflammatory, Th2, and regulatory responses, suggesting robust immune activation. In contrast, the UgCl377 strain elicited a dampened cytokine profile. While this study does not isolate the effect of CNAG_04922 alone, it demonstrates that whole-cell antigens from genetically distinct strains of C. neoformans elicit differential cytokine responses. These findings provide a foundation for future mechanistic studies using purified proteins or isogenic strains.
Keywords: cnag_04922; cryptococcal meningitis; cryptococcosis; cryptococcus neoformans; cytokine response; gene alleles; host-pathogen interaction; pro-inflammatory cytokines; single nucleotide polymorphism; tnf-alpha.
Copyright © 2025, Kassaza et al.
Conflict of interest statement
Human subjects: Informed consent for treatment and open access publication was obtained or waived by all participants in this study. Mbarara University of Science and Technology Research Ethics Committee issued approval MUST-2022-743. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: This study was supported by a grant from the National Institute of Neurological Disorders and Stroke (NINDS) and the Fogarty International Center (FIC), grant number R01NS118538. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.
Figures
References
-
- High burden of cryptococcal meningitis among antiretroviral therapy-experienced human immunodeficiency virus-infected patients in northern Uganda in the era of “test and treat”: implications for cryptococcal screening programs. Okwir M, Link A, Rhein J, et al. Open Forum Infect Dis. 2022;9:0. - PMC - PubMed
LinkOut - more resources
Full Text Sources
Research Materials